Skip to content

Effect of Wild Mint product in Postprandial Distress Syndrome

Assessment of effect of Wild Mint product in Postprandial Distress Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013043013183N1
Enrollment
100
Registered
2013-06-03
Start date
2013-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia. Indigestion

Interventions

Intervention 1: Intervention group: Wild Mint Capsules 500 mg? For 4 weeks? Three times daily after meals. Intervention 2: placebo: Corn starch Capsules 500 mg? For 4 weeks? Three times a daily after
Treatment - Drugs
Placebo
Intervention group: Wild Mint Capsules 500 mg? For 4 weeks? Three times daily after meals
placebo: Corn starch Capsules 500 mg? For 4 weeks? Three times a daily after meals

Sponsors

shahed University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with 18-65 old years? Early Satiety? bothersome postprandial fullness? Without Organic Disorders on physical examination and Endoscopic Exclusion criteria: Patients with organic disorders? The use of Chemicals and Herbals any other medication? History of Abdominal surgeries? History of bloody diarrhea? Pregnancy and lactation? Lack of interest in work? Not sign the consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity Assessment of Dyspepsia. Timepoint: At baseline,at 2,4,12 weeks. Method of measurement: The Gastrointestinal Symptom Scale.;Quality of life. Timepoint: At Baseline? at 12 Weeks. Method of measurement: SF-36 Questionnaire.

Secondary

MeasureTime frame
Side Effects. Timepoint: During the 12-week follow-up study. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmoud Babaeian

Shahed University of Medical Sciences

drbabaeian@yahoo.com+98 21 2288 2521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026